Nike Inc. (NKE): HSBC maintains Hold on Nike as a delayed turnaround faces weakening demand and stronger competitive pressure.

Overview

HSBC views Nike as facing an uphill turnaround: macro weakness, heavier promotions, China disruption and better-positioned competitors are delaying recovery. It maintains Hold and lowers its DCF-based target price to USD40, arguing that the November Investor Day is unlikely to substitute for delivered financial improvement.

Core views

HSBC expects Nike’s Q1 FY27 results, due 1 October, to broadly meet management guidance and consensus for the reported quarter, but anticipates a cautious outlook. Its Q1 forecast is group sales of USD11.302bn, down 4% year on year, group EBIT of USD805m, down 13%, and a 7.1% EBIT margin, down 79bp. The institution expects Q2 sales growth to decelerate sequentially as the World Cup benefit fades and promotions and wholesale shipments are phased differently. It also believes consensus may not yet fully capture the sales impact of Nike’s digital distribution overhaul in China, while weaker European consumer demand could further delay recovery. HSBC’s market checks point to mixed demand indicators and mounting margin pressure. Nike web traffic returned to growth in June and was up 10% year on year in August according to Similarweb, likely helped by the World Cup. However, adidas recorded much stronger traffic growth through July, reaching 78% year on year before moderating to 21% in August. Nike also increased promotions: discounted SKUs on its e-commerce sites in key markets rose 33% since July 2026 and 15% since April 2026. HSBC believes discounts can clear legacy silhouettes but will add pressure to margins. The competitive backdrop is a central obstacle. Recent events by Salomon, On and adidas reinforced HSBC’s view that those brands have strong innovation pipelines, growth ambitions and expanding distribution. On targets high-teens mid-term sales CAGR, Salomon mid-teens, and adidas high-single-digit growth, alongside margin expansion. Salomon and On are also broadening product categories and sports while expanding direct-to-consumer and selective wholesale distribution. HSBC contrasts this with Nike’s currently stagnant portfolio, limited innovation and stale product offering. HSBC cuts FY27-29 EBIT estimates by about 5%, citing weaker sales growth and operating deleverage. For FY27, it forecasts organic sales growth of -3.1% versus -1.6% previously, gross margin of 41.2% versus 41.3%, and EBIT margin of 6.6% versus 7.0%; the gross margin would be down about 170bp year on year, though up 50bp adjusted for one-off US tariff refunds. For FY28, it lowers organic growth to 2.2% from 4.2% and EBIT margin to 7.7% from 8.0%. For FY29, it forecasts 4.0% organic growth versus 4.3% previously and an 8.7% EBIT margin versus 8.5% previously. EPS forecasts are USD1.64, USD1.94 and USD2.27 for FY27-FY29, respectively. The target price reduction to USD40 from USD48 reflects the estimate cuts and a higher WACC of 9.7%, up from 9.1%. HSBC increased its sector beta assumption to 1.40 from 1.20 because of the sporting-goods cyclical downturn and weakening demand; the risk-free rate remains 4.25%, equity risk premium 4.00%, and specific beta 0.95. Although the USD40 target implies about 11% upside from USD35.99, HSBC retains Hold because it sees no short-term catalyst. It expects the 16-17 November Investor Day to update investors on the turnaround, products and FY27 guidance, but regards Nike as a “show-me” story where financial delivery will matter more than commitments. “Win Now” actions are expected to end by CY26, while more than a dozen lifestyle footwear launches are not planned until Spring 2027 and are expected to scale through CY27.

Analysis framework

HSBC combines a Q1 FY27 earnings preview with regional sales assumptions, web-traffic and e-commerce discount checks, peer innovation and growth comparisons, multi-year earnings revisions, and DCF valuation. It then evaluates whether the timing of product launches and the Investor Day can provide a near-term catalyst.

Methodology notes

• Valuation methodsDCF (Discounted Cash Flow)

  DCF-derived target price

  HSBC values Nike by discounting projected cash flows. The target price falls as earnings forecasts are reduced and the discount rate rises to a 9.7% WACC.

• Industry AnalysisVolume-price decomposition

  Sales growth and promotional discounting analysis

  The report assesses traffic, sales growth and discount penetration to judge demand momentum, inventory clearance and the likely effect of promotions on margins.

• Competition & strategyEconomic Moat and Competitive Advantage

  Peer innovation and distribution comparison

  HSBC compares Nike’s product pipeline and distribution position with those of On, Salomon and adidas to assess competitive pressure and turnaround difficulty.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Nike Inc. (NKE US)

  Primary covered company; its turnaround is being delayed by weak demand, promotions and competition.

  Strengths

  Nike web traffic was up 10% year on year in August, and more than a dozen lifestyle footwear launches are planned from Spring 2027.

  Weaknesses

  Portfolio appears stagnant with limited innovation; heavier discounting is expected to pressure margins.

  Comparison

  HSBC views On, Salomon and adidas as having stronger innovation pipelines and ambitious growth and distribution plans.

  Risks

  Slower sales recovery, weaker western-market demand, China disruption and share losses could worsen results.

• adidas (ADS GR)

  Competitor used to benchmark Nike’s traffic, innovation and competitive position.

  Strengths

  HSBC cites strong innovation capabilities, a product pipeline and high-single-digit mid-term sales CAGR ambition.

  Comparison

  adidas web traffic was up 78% year on year in July and 21% in August, compared with Nike’s 10% August growth.

• On (ONON US)

  Competitor highlighting intensifying pressure on Nike.

  Strengths

  HSBC cites strong innovation, high-teens mid-term sales CAGR ambitions and distribution expansion.

  Comparison

  On is expanding across categories and sports and developing DTC and selective wholesale distribution.

• Salomon (part of Amer Sports; AS US)

  Competitor cited as evidence of a stronger peer innovation pipeline.

  Strengths

  HSBC cites strong innovation, mid-teens sales CAGR ambitions and category and distribution expansion.

  Comparison

  HSBC believes Salomon’s strategic expansion adds competitive pressure on Nike.

Key data

• Target priceUSD40.00Reduced from USD48.00; implies about 11% upside.
• Share priceUSD35.99As of 24 Sep 2026.
• FY27 organic sales growth forecast-3.1%Previously -1.6%.
• FY27 EBIT margin forecast6.6%Previously 7.0%; down about 150bp year on year.
• FY27-29 EBIT estimate changec-5%Cut because of weaker sales growth and operating deleverage.
• WACC9.7%Raised from 9.1%; sector beta increased to 1.40 from 1.20.
• Discounted Nike SKUs+33% since July 2026; +15% since April 2026HSBC’s e-commerce checks in key markets.

Impact & implications

HSBC argues that Nike’s recovery will require demonstrated financial delivery rather than forward-looking announcements. Greater promotions may help clear older products but weaken margins, while delayed new-product availability and stronger competitor pipelines limit the scope for a near-term re-rating catalyst.

Risks

• Downside risk: a slower-than-expected sales recovery, including worsening US and other western-market trading as inflation affects consumption.
• Downside risk: a stronger US dollar, production disruption in China or elsewhere in Asia, or a prolonged China weakness that extends market-share losses.
• Downside risk: consumer boycotts of American brands in certain markets.
• Upside risk: greater operating leverage from a higher mix of full-price sales or restructuring benefits.
• Upside risk: a weaker US dollar, stronger value-investor interest, or a better-than-expected short-term product pipeline.

What to watch

• Nike’s Q1 FY27 results and management’s outlook for Q2 and the period ahead.
• The impact of the China digital distribution overhaul and demand trends in Europe and other western markets.
• Nike’s promotional intensity and its effect on gross and EBIT margins.
• The 16-17 November Investor Day update on turnaround progress, product initiatives, FY27 guidance and longer-term growth.
• Timing and scaling of lifestyle footwear launches from Spring 2027 through CY27.